Pfizer Seeks To Invest In More Early Stage Research
Pfizer Seeks To Invest In More Early Stage Research Companies
Source: Dow Jones News
By Ezequiel Minaya
Pfizer Inc. said Friday that it was broadening its investment strategy linked to research and development to include partnerships with "early-stage" companies.
The drug maker said the first four companies to benefit from its eased restrictions would receive $46 million in financing. The investment targets were seen as conducting research in promising areas aligned with Pfizer's core interests, the company said in a news release.
The new partners included Bioatla, Nextcure Inc., Cortexyme Inc. and 4D Molecular Therapeutics Inc. Pfizer said the companies were at the early stages of research in conditionally active biologics, immuno-oncology, neurodegenerative technologies and gene therapy.
"The key for Pfizer is to be flexible in how we partner with different companies; we use a range of investment vehicles and collaboration models in R&D," said Mikael Dolsten, president of Pfizer worldwide research and development.
In November, Pfizer and Dublin-based Allergan PLC said they would merge in a so-called inversion deal that was initially valued at about $155 billion and would create the world's biggest drug maker by sales.
Such deals enable a U.S. company to move abroad and take advantage of a lower corporate tax rate elsewhere, and they have remained popular in the face of U.S. efforts to curb them.
Write to Ezequiel Minaya at Ezequiel.Minaya@wsj.com
(END) Dow Jones Newswires
January 08, 2016 17:05 ET (22:05 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Award Recap: The Best of Yeastar’s Yeahs 2026 Blasting out of the gates here with some hefty recognition at the Yeahs Awards 2026—Yeastar is slinging accolades like confetti at a wedding. What’s the deal? It’s all about their partners and their slick moves in Unified Communications (UC). These tech whizzes are racking up milestones in AI, cloud services, and...
Continue Reading
Sparks Fly Between Chemours and Its Investors There ain't no rest for the weary, especially in the cutthroat world of stocks where one misstep can have ripple effects far and wide. Today, we're eyeballing The Chemours Company (NYSE: CC), sitting right in the bullseye as shareholders light the torches and march for justice. Class Action Suit: The Lay of the Land Alright...
Continue Reading
Cracks in Cerebras' Processor Promises? When you dance with high-stakes tech stocks, sometimes you end up stepping on a few toes. This seems to ring true as Cerebras Systems (CBRS) dances its way into hot water. Allegations from Culper Research suggest their fancy AI processors, which are supposed to be the poster children of reliability, might bow out early. Digging...
Continue Reading
EDB's Ambitious Move Into Seamless Data Growth Right out of Wilmington, Delaware, EnterpriseDB (EDB) is sowing the seeds for a seismic change in how enterprises juggle their data systems. With 86% of the top brass anticipating AI data systems becoming top-tier indispensable, the unveiling of EDB’s horizontal scaling for their Postgres AI Distributed is a tune you just...
Continue Reading
In the ever-evolving dance of political discourse, a new book strides onto the stage: Not My President, published by Palmetto Publishing. It’s a bold compilation of presidential utterances, capturing the words of Donald J. Trump in all their unvarnished glory. Stripped of analysis or comedic flair, each entry stands alone like a solitary figure at a cocktail party,...
Continue Reading
A Night Celebrating Service and Sacrifice You know, in times like these, it’s refreshing to see events that focus on giving back rather than taking everything to the bank. Victory Home Remodeling, along with its nonprofit arm, the Victory Foundation, recently hosted their second annual gala in Woodland Park, New Jersey to give some much-needed limelight to those who put...
Continue Reading
A New Era for MPLX's Board Nothing shakes up the scene like announcing two heavyweights joining the board, and that's exactly what MPLX LP (NYSE: MPLX) just pulled off. Micheal G. Dunn and Bruce L. Niemeyer are coming onboard, effective November 1, 2026. With pedigrees that could make any industry insider nod in approval, these guys bring decades of experience to the...
Continue Reading
RPC Rides Out a Rough Quarter with Strategic Moves Ah, the oilfield services game—never a dull moment, right? RPC, Inc. just dropped their Q3 2026 results, and there’s a mixed bag to digest here. On the one hand, they saw a modest 1% uptick in revenue, hitting $467.7 million. But on the flip side, they're grappling with a hefty net loss of $41.9 million thanks to a...
Continue Reading
Opening Up New Avenues for Health Care Here's a nugget from the healthcare sector that's worth chewing on. Shield HealthCare has just inked a deal with Astiva Health that opens the floodgates for eligible members in Southern California to access medical supplies through Shield's extensive network. It's a big move that aims to make health management a tad easier for folks...
Continue Reading
Hanwha and Chainlink: A Game Changer in Tokenization What do Hanwha Investment & Securities, a heavyweight in Korea's finance scene, and Chainlink, the wizard of onchain finance, think they're up to? They're buddies now, locked and loaded, to tokenize real-world assets (RWAs). They're not just shaking hands; they're aiming to jiggle the global finance bedrock....
Continue Reading
Top 5 Most Recently Viewed Articles
Finding the Perfect Neighborhood: Insights from Ryan Lerwill Homebuyers often face the challenge of choosing a neighborhood that suits their preferences and lifestyle. Ryan Lerwill, a renowned real estate expert, offers invaluable advice on making this important decision. In his recent discussion, he emphasizes the significance of various factors that influence how...
Continue Reading
Understanding Recent Market Dynamics Today offers an opportunity to gain valuable insights into market movements driven by economic data and trends. As we delve into the intricate world of investing, understanding these fluctuations is essential. Critical Economic Data on the Horizon Investors should focus on two significant economic indicators scheduled for release soon....
Continue Reading
Introducing Bold New Flavors from Hillshire Farm® Tyson Foods is excited to invigorate the lunch meat category with the launch of the new Hillshire Farm Sandwich Style Lunch Meats. These innovative products are designed to not only satisfy hunger but also to elevate the everyday meal experience with exciting flavors. Explore the New Flavors Hillshire Farm has unveiled...
Continue Reading
Technetium-99m Market Overview The Technetium-99m market is undergoing remarkable growth due to its critical use in medical diagnostics. Particularly known for its application in imaging chronic and non-communicable diseases, the market value stands at approximately US$ 6.0 billion. Projections indicate that this value could grow by a compound annual growth rate (CAGR) of...
Continue Reading
Jazz Chisholm Jr. Joins Once Upon a Coconut Once Upon a Coconut is making waves in the coconut water industry, and now they have an exciting new partner: Jazz Chisholm Jr., the talented second baseman for the New York Yankees. This partnership highlights Chisholm's dynamic nature, not just as an athlete but as a passionate advocate for positive change. Known for his...
Continue Reading